Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 138,752,791
- Total 13F shares
- 91,862,480
- Share change
- -816,696
- Total reported value
- $130,443,350
- Price per share
- $1.42
- Number of holders
- 95
- Value change
- -$2,093,251
- Number of buys
- 51
- Number of sells
- 64
Quarterly Holders Quick Answers
What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00461U105:
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
|
Company |
10%
|
14,250,000
|
$21,802,500 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
6.9%
|
9,627,304
|
$14,729,775 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
6.4%
|
8,888,888
|
$13,599,999 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
5,046,309
|
$7,720,853 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
4,970,254
|
$7,604,488 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.4%
|
4,666,667
|
$7,140,001 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
13D/G
|
Company |
3.5%
from 13D/G
|
4,134,148
|
$6,325,246 | — | 31 Mar 2025 | |
| Decheng Capital LLC |
13F
|
Company |
2.9%
|
4,041,736
|
$6,183,856 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.1%
|
2,944,512
|
$4,505,103 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
2,415,584
|
$3,695,843 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.7%
|
2,312,926
|
$3,538,777 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
1.6%
|
2,222,222
|
$3,400,000 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,195,191
|
$3,355,000 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.38%
|
527,842
|
$2,766,143 | — | 31 Mar 2025 | |
| Bollard Group LLC |
13F
|
Company |
1%
|
1,424,176
|
$2,179,000 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1%
|
1,381,741
|
$2,114,064 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.98%
|
1,361,037
|
$2,082,387 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.97%
|
1,350,820
|
$2,066,755 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.85%
|
1,182,737
|
$1,810,169 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.81%
|
1,122,081
|
$1,716,784 | — | 31 Mar 2025 | |
| Aldebaran Capital, LLC |
13F
|
Company |
0.73%
|
1,007,958
|
$1,542,176 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.69%
|
951,394
|
$1,455,633 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.67%
|
923,313
|
$1,412,669 | — | 31 Mar 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.64%
|
888,888
|
$1,359,999 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.62%
|
865,011
|
$1,323,467 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.62%
|
858,400
|
$1,313,352 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.59%
|
820,264
|
$1,255,004 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.56%
|
776,028
|
$1,187,323 | — | 31 Mar 2025 | |
| Anand Mehra |
3/4/5
|
Director |
—
mixed-class rows
|
757,173
mixed-class rows
|
$1,098,616 | — | 05 Jun 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
0.5%
|
695,573
|
$1,064,227 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.49%
|
681,553
|
$1,042,776 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
555,953
|
$850,608 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.36%
|
498,721
|
$763,043 | — | 31 Mar 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.33%
|
460,842
|
$705,088 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.33%
|
458,184
|
$701,021 | — | 31 Mar 2025 | |
| Andrew N. Schiff |
3/4/5
|
Director |
—
mixed-class rows
|
490,765
mixed-class rows
|
$691,011 | — | 05 Jun 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
0.31%
|
434,455
|
$664,716 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.29%
|
407,525
|
$623,513 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.28%
|
390,282
|
$597,131 | — | 31 Mar 2025 | |
| Joseph Monahan |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
570,280
mixed-class rows
|
$550,792 | — | 01 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.26%
|
354,849
|
$543,255 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.25%
|
348,917
|
$533,843 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.23%
|
316,064
|
$483,578 | — | 31 Mar 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.22%
|
311,712
|
$476,919 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
288,719
|
$441,740 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
269,086
|
$411,701 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.18%
|
250,805
|
$383,732 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
0.14%
|
197,748
|
$302,554 | — | 31 Mar 2025 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.13%
|
177,558
|
$271,664 | — | 31 Mar 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.13%
|
175,900
|
$269,127 | — | 31 Mar 2025 |
Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q2 2025
As of 30 Jun 2025,
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,862,480 shares.
The largest 10 holders included
BML Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Vivo Capital, LLC, VANGUARD GROUP INC, BlackRock, Inc., Rock Springs Capital Management LP, Decheng Capital LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and D. E. Shaw & Co., Inc..
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
106
Q2 2025 holders
95
Holder diff
-11
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.